-
公开(公告)号:EP3728331B1
公开(公告)日:2023-08-16
申请号:EP18826656.3
申请日:2018-12-20
发明人: KLEINERT, Mike
IPC分类号: C08B11/08
-
公开(公告)号:EP4204644A2
公开(公告)日:2023-07-05
申请号:EP21811135.9
申请日:2021-10-28
发明人: BESNIER, Arnaud , FAVIE, Louis , MAZET, Pierre , DELOCHE, Remi
IPC分类号: E04H4/16
-
3.
公开(公告)号:EP4177355A1
公开(公告)日:2023-05-10
申请号:EP21834599.9
申请日:2021-05-07
发明人: RYU, Hyun Mee , LIM, Ji Hyae
IPC分类号: C12Q1/6883
摘要: Provided are a method of providing information for diagnosing Down syndrome and a method of diagnosing Down syndrome, the method comprising measuring a methylation level of a Down syndrome biomarker in a biological sample separated from a fetus, comparing the measured methylation level of the biomarker with a methylation level of the first biomarker and the second biomarker in the biological sample separated from a normal control group, and determining a presence or a risk of Down syndrome by comparing the methylation level, wherein the biomarker is a first biomarker present on chromosome 21, a second biomarker present on a chromosome other than chromosome 21, or a combination thereof. Thus, Down syndrome can be diagnosed early with high accuracy, and the disclosure is expected to be applied as a key technology in the field of Down syndrome diagnosis.
-
公开(公告)号:EP4177354A1
公开(公告)日:2023-05-10
申请号:EP21832194.1
申请日:2021-05-07
发明人: RYU, Hyun Mee , LIM, Ji Hyae
IPC分类号: C12Q1/6883
摘要: Provided are a composition for diagnosing Down syndrome, a kit including the composition, a diagnostic method, and a method of providing information for diagnosing Down syndrome, the composition including an agent for measuring a methylation level of any one gene selected from the group consisting of MXRA8, MIB2, KIF26B, SP5, ZIC4, ENPEP, PITX2, SH3BP2, SEPP1, FLJ32255, SHROOM1, LINC00574, LOC154449, PRRT4, TMEM176B, MNX1, LOC101928483, EGFL7, NACC2, C9orf69, TLX1, FGF8, TACC2, CPXM2, NKX6-2, TLX1NB, IQSEC3, PCDH8, F7, SOX9, PNMAL2, THBD, MAPK8IP2, KLHDC7B, GPR143, IGHMBP2, MRGPRD, CHODL, NCAM2, CYYR1, GRIK1, OLIG2, CLIC6, SIM2, HLCS, MX2, MX1, TMPRSS2, SLC37A1, PDE9A, CBS, CRYAA, C21orf2, TRPM2, TSPEAR, LINC00162, SSR4P1, SLC19A1, LOC100129027, MCM3AP, YBEY, PRMT2, and ITSN1. Thus, Down syndrome can be diagnosed early with high accuracy, and the disclosure is expected to be applied as key a technology in the field of Down syndrome diagnosis.
-
5.
公开(公告)号:EP4150094A1
公开(公告)日:2023-03-22
申请号:EP21804219.0
申请日:2021-05-11
发明人: PETROU, Steven
IPC分类号: C12N15/113 , C12N9/14 , A61P25/28 , C07K14/47
-
公开(公告)号:EP4067506A1
公开(公告)日:2022-10-05
申请号:EP20893105.5
申请日:2020-11-10
发明人: HWANG, So Hyun , LIM, Jae Joon , CHA, Kwang Yul , AN, Hee Jung , KANG, Hae Youn , CHO, Kyung Gi , HEO, Jin Hyung , JOUNG, Je-Gun , KIM, Se Wha , KWON, Ah Young
IPC分类号: C12Q1/6886 , G01N33/574
摘要: The disclosure relates to biomarkers for predicting a therapeutic response of a patient to an immune cell therapy. Since gene signatures and markers according to an aspect have an excellent predictive capacity for predicting a patient's therapeutic response to an immune cell therapy, a patient group predicted to exhibit therapeutic effects may be selected to perform an appropriate treatment, and a patient's suffering and costs may be reduced.
-
公开(公告)号:EP4050058A1
公开(公告)日:2022-08-31
申请号:EP21159608.5
申请日:2021-02-26
申请人: Rudolf GmbH
IPC分类号: C08G77/388 , C09D183/10 , D06M15/643 , D06M15/564 , D06M15/568 , C09D183/08
摘要: Die Erfindung betrifft Organopolysiloxane enthaltend mindestens eine Struktureinheit mit mindestens einer C 8-28 -Alkylgruppe und mindestens einer Harnstoffgruppe, ein Verfahren zu deren Herstellung, eine Zubereitung umfassend das Organopolysiloxan, sowie die Verwendung als Hydrophobierungsmittel.
-
公开(公告)号:EP4047951A1
公开(公告)日:2022-08-24
申请号:EP20877231.9
申请日:2020-10-11
发明人: LI, Shihuang
摘要: Provided in the present invention is a stereo sound box, including: a box body. Two sets of sound generating units are provided on a surface of the box body, correspondingly for a left sound channel and a right sound channel. Each set of sound generating units includes a low sound unit and at least one high sound unit. The low sound units of the two sets of sound generating units are arranged to mirror each other so as to neutralize the inertia of vibrations. The high sound units are arranged outside each low sound unit. In the described stereo sound box, high-fidelity low sound can be maintained even while the box body is kept light.
-
9.
公开(公告)号:EP4011836A1
公开(公告)日:2022-06-15
申请号:EP20850136.1
申请日:2020-08-06
发明人: SATOMI, Naotoshi , IIDA, Yasutaka
摘要: Provided is a nickel composite hydroxide that was excellent in reactivity to a lithium compound and a positive electrode active material using the nickel composite hydroxide as a precursor. The nickel composite hydroxide, having an average diameter of pores of 50 Å or larger and 60 Å or smaller in pore distribution measurement by a nitrogen adsorption method and an integrated intensity ratio of a diffraction peak appearing in a range of 2θ = 51.9 ± 1.0°/a diffraction peak appearing in a range of 2θ = 19.1 ± 1.0° in powder X-ray diffraction using CuKα rays of 0.40 or more and 0.50 or less.
-
公开(公告)号:EP3949913A1
公开(公告)日:2022-02-09
申请号:EP20778610.4
申请日:2020-03-25
发明人: SUNG, Jung Hoon , JUNG, Bo Young , YANG, Pil Sung
摘要: The present invention provides a drug-eluting stent. The present invention includes a main structure, and a drug delivery layer that is applied to the main structure and includes a fibrosis drug, wherein, when the main structure comes into contact with a target tissue, the fibrosis drug of the drug delivery layer is released into the target tissue to perform fibrous of the target tissue.
-
-
-
-
-
-
-
-
-